EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing current capabilities and barriers to performing routine laboratory tests on patients with suspected high consequence infectious disease at frontline acute care hospitals

Madeline A DiLorenzo iD, Anthony Joseph Lo Piccolo iD, Jared Bosk, Dina Shapiro-Luft, Paul Biddinger iD, Nahid Bhadelia iD, Tani Jausurawong, Christopher Sulmonte iD, Dana Mazo iD, Michael Phillips iD, Jessica L Jacobson iD, Vikramjit Mukherjee iD und 1 weitere

Infection Control & Hospital Epidemiology · 2026

DOI: 10.1017/ice.2026.10465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection Control & Hospital Epidemiology, 2026. Verfasst von Madeline A DiLorenzo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and Immunology, Department of Medicine, New York University Grossman School of Medicine, USA. Hauptthemen laut MEDLINE: Diagnostic Tests, Routine, Laboratories, Hospital, Hospitals. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Patients with a suspected high-consequence infectious disease (HCID), such as Ebola virus disease, may require routine laboratory testing to guide management. We assessed the capabilities of frontline hospitals and the barriers they face performing laboratory testing for patients with a suspected HCID.

Methods

A one-time confidential REDCap survey querying capabilities to safely perform laboratory tests that the Centers for Disease Control and Prevention considers critical for patients with a suspected HCID was sent to 95 institutions in Baltimore, MD, Boston, MA, New York City, NY, and Washington, DC, from January to May 2025.

Results

Fifty (53%) institutions responded, mostly teaching hospitals (96%), with 24% reporting prior experience evaluating a patient with suspected Ebola virus disease. While many hospitals could perform on-site blood gas (70%), hemoglobin/hematocrit (68%), and lactate (68%) tests on a suspected HCID patient, fewer could safely perform a chemistry panel (64%), a urinalysis (60%), a complete blood count with differential (56%), and a malaria rapid diagnostic test (RDT) (48%) on a suspected HCID patient. The five tests respondents most often considered extremely or very important were hemoglobin/hematocrit (91%), chemistry panel (90%), CBC with differential and platelet count (89%), malaria RDT (88%), and blood gas (88%). Reported barriers to performing routine laboratory testing included issues related to patient and staff safety, infection control, lack of appropriate space, and funding.

Conclusions

Our survey identified several barriers to implementing safe laboratory testing. The inability to conduct these laboratory tests may result in delays in care when an HCID is suspected.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diagnostic Tests, RoutineLaboratories, HospitalHospitalsHumansUnited StatesHemorrhagic Fever, Ebola

Autor:innen und Institutionen

  • Division of Infectious Diseases and Immunology, Department of Medicine, New York University Grossman School of Medicine, USA.
  • Division of Infectious Diseases and Immunology, Department of Medicine, New York City Health + Hospitals/Bellevue, USA.
  • Special Pathogens Program, NYC Health + Hospitals/Bellevue, USA.
  • Survey and Outcomes Research, Greater New York Hospital Association, USA.
  • Department of Emergency Medicine, Massachusetts General Hospital, USA.
  • Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, USA.

ORCID-Profile: Madeline A DiLorenzo, Anthony Joseph Lo Piccolo, Paul Biddinger, Nahid Bhadelia, Christopher Sulmonte, Dana Mazo, Michael Phillips, Jessica L Jacobson, Vikramjit Mukherjee, Justin Chan

Zitieren

APA

DiLorenzo, M. A., Lo Piccolo, A. J., Bosk, J., Shapiro-Luft, D., Biddinger, P., Bhadelia, N., Jausurawong, T., Sulmonte, C., Mazo, D., Phillips, M., Jacobson, J. L., Mukherjee, V., & Chan, J. (2026). Assessing current capabilities and barriers to performing routine laboratory tests on patients with suspected high consequence infectious disease at frontline acute care hospitals. Infection Control & Hospital Epidemiology. https://doi.org/10.1017/ice.2026.10465

Vancouver

DiLorenzo MA, Lo Piccolo AJ, Bosk J, Shapiro-Luft D, Biddinger P, Bhadelia N, et al. Assessing current capabilities and barriers to performing routine laboratory tests on patients with suspected high consequence infectious disease at frontline acute care hospitals. Infection Control & Hospital Epidemiology. 2026. doi:10.1017/ice.2026.10465

BibTeX
@article{DiLorenzo2026,
  author = {DiLorenzo, Madeline A and Lo Piccolo, Anthony Joseph and Bosk, Jared and Shapiro-Luft, Dina and Biddinger, Paul and Bhadelia, Nahid and Jausurawong, Tani and Sulmonte, Christopher and Mazo, Dana and Phillips, Michael and Jacobson, Jessica L and Mukherjee, Vikramjit and Chan, Justin},
  title = {Assessing current capabilities and barriers to performing routine laboratory tests on patients with suspected high consequence infectious disease at frontline acute care hospitals},
  journal = {Infection Control & Hospital Epidemiology},
  year = {2026},
  doi = {10.1017/ice.2026.10465}
}
Kostenlos starten →